Net Cash Provided by (Used in) Financing Activities in USD of Enveric Biosciences, Inc. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Enveric Biosciences, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2025.
  • Enveric Biosciences, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $4.45M, a 33.2% decline year-over-year.
  • Enveric Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $7.67M.
  • Enveric Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$1.34M, a 107% decline from 2022.
  • Enveric Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $18.2M, a 27% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Enveric Biosciences, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $4.45M -$2.21M -33.2% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q1 2024 $6.66M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q1 2022 $9.4M -$15.5M -62.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $24.9M +$25M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2020 -$108K -$1.56M -107% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2019 $1.45M +$3.04M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q1 2018 -$1.59M -$2.93M -219% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q1 2017 $1.34M +$1.1M +454% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q1 2016 $241K +$116K +93.2% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-16
Q2 2015 $5.03M +$4.91M +3928% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-18
Q1 2015 $125K +$75K +150% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q2 2014 $125K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-18
Q1 2014 $50K +$38K +317% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q1 2013 $12K Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-05-08

Enveric Biosciences, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $7.67M +$9.02M Jan 1, 2024 Dec 31, 2024 10-K 2025-03-28
2023 -$1.34M -$19.5M -107% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-28
2022 $18.2M -$6.72M -27% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $24.9M +$19.4M +350% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-06-09
2020 $5.53M +$4.97M +888% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $560K -$2.13M -79.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-01
2018 $2.69M -$3.72M -58% Jan 1, 2018 Dec 31, 2018 10-K/A 2020-08-12
2017 $6.41M -$2.39M -27.1% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-26
2016 $8.8M +$2.56M +41.1% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $6.24M +$6.19M +12892% Jan 1, 2015 Dec 31, 2015 10-K/A 2017-04-04
2014 $48K +$27.5K +134% Jan 1, 2014 Dec 31, 2014 10-K 2015-03-31
2013 $20.5K +$12.5K +156% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
2012 $8K -$39.5K -83.1% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-28
2011 $47.5K +$7.45K +18.6% Jan 1, 2011 Dec 31, 2011 10-K 2013-02-28
2010 $40K Jan 1, 2010 Dec 31, 2010 10-K 2012-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.